ArticleOncoimmunology2020

Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome.

Kim L Brunekreeft et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.